Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inflammatory profiles of severe treatment-resistant depression
Rebecca Strawbridge, John Hodsoll, Timothy R. Powell, et al.
Journal of Affective Disorders (2018) Vol. 246, pp. 42-51
Open Access | Times Cited: 103

Showing 1-25 of 103 citing articles:

Impact of COVID-19 in the Mental Health in Elderly: Psychological and Biological Updates
Roberta Eduarda Grolli, Maiqueli Eduarda Dama Mingoti, Amanda Gollo Bertollo, et al.
Molecular Neurobiology (2021) Vol. 58, Iss. 5, pp. 1905-1916
Open Access | Times Cited: 229
Gut Microbiota in Anxiety and Depression: Unveiling the Relationships and Management Options
Akash Kumar, Jhilam Pramanik, Nandani Goyal, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 565-565
Open Access | Times Cited: 50
Changes in inflammatory biomarkers are related to the antidepressant effects of Ayahuasca
Nicole Leite Galvão‐Coelho, Ana Cecília de Menezes Galvão, Raíssa Nóbrega de Almeida, et al.
Journal of Psychopharmacology (2020) Vol. 34, Iss. 10, pp. 1125-1133
Closed Access | Times Cited: 103
Novel drug developmental strategies for treatment‐resistant depression
Éva Borbély, Mária Simon, Eberhard Fuchs, et al.
British Journal of Pharmacology (2021) Vol. 179, Iss. 6, pp. 1146-1186
Open Access | Times Cited: 71
Rheumatoid arthritis and depression
É. Fakra, Hubert Marotte
Joint Bone Spine (2021) Vol. 88, Iss. 5, pp. 105200-105200
Closed Access | Times Cited: 70
Psycho-Pharmacomicrobiomics: A Systematic Review and Meta-Analysis
Amedeo Minichino, Tabitha Preston, Jack B. Fanshawe, et al.
Biological Psychiatry (2023) Vol. 95, Iss. 7, pp. 611-628
Open Access | Times Cited: 24
Pro-inflammatory cytokines in stress-induced depression: Novel insights into mechanisms and promising therapeutic strategies
Jun Chang, Tingcan Jiang, Xiaoqian Shan, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 131, pp. 110931-110931
Closed Access | Times Cited: 16
Sex differences in the inflammation-depression link: A systematic review and meta-analysis
Dana A. Jarkas, Ally H. Villeneuve, Ayeila Z.B. Daneshmend, et al.
Brain Behavior and Immunity (2024) Vol. 121, pp. 257-268
Open Access | Times Cited: 12
Distinguishing features of depression in dementia from primary psychiatric disease
Daniel Fisher, Jeffrey T. Dunn, Hongxin Dong
Discover Mental Health (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 9
Biomarkers for response in major depression: comparing paroxetine and venlafaxine from two randomised placebo-controlled clinical studies
Lucia Carboni, Dennis J. McCarthy, Bruno Delafont, et al.
Translational Psychiatry (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 65
Practical recommendations for the management of treatment-resistant depression with esketamine nasal spray therapy: Basic science, evidence-based knowledge and expert guidance
Siegfried Kasper, Wiesław Jerzy Cubała, Andrea Fagiolini, et al.
The World Journal of Biological Psychiatry (2020), pp. 1-15
Open Access | Times Cited: 62
Inflammatory proteins are altered in chronic fatigue syndrome—A systematic review and meta-analysis
Rebecca Strawbridge, Maria-Laura Sartor, Fraser Scott, et al.
Neuroscience & Biobehavioral Reviews (2019) Vol. 107, pp. 69-83
Closed Access | Times Cited: 60
Childhood trauma, suicide risk and inflammatory phenotypes of depression: insights from monocyte gene expression
Carmen Schiweck, Stephan Claes, Lukas Van Oudenhove, et al.
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 52
Neuroinflammation and Mitochondrial Dysfunction Link Social Stress to Depression
Fiona Hollis, Brittany S. Pope, Erin Gorman‐Sandler, et al.
Current topics in behavioral neurosciences (2022), pp. 59-93
Closed Access | Times Cited: 34
Renin-angiotensin system: The underlying mechanisms and promising therapeutical target for depression and anxiety
Sizhu Gong, Fang Deng
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 18
Serum cytokines-based biomarkers in the diagnosis and monitoring of therapeutic response in patients with major depressive disorder
Yayun Xu, Jun Liang, Yanhong Sun, et al.
International Immunopharmacology (2023) Vol. 118, pp. 110108-110108
Closed Access | Times Cited: 18
Treatment-resistant depression with anhedonia: Integrating clinical and preclinical approaches to investigate distinct phenotypes
Chris Kelly, Kevin B. Freeman, Julie A. Schumacher
Neuroscience & Biobehavioral Reviews (2022) Vol. 136, pp. 104578-104578
Closed Access | Times Cited: 27
Efficacy of infliximab in treatment-resistant depression: A systematic review and meta-analysis
Daniela Vicente Bavaresco, Maria Laura Rodrigues Uggioni, Sarah Dagostin Ferraz, et al.
Pharmacology Biochemistry and Behavior (2019) Vol. 188, pp. 172838-172838
Closed Access | Times Cited: 42
Neuroinflammation in psychiatric disorders: An introductory primer
Geoffrey A. Dunn, Jennifer M. Loftis, Elinor L. Sullivan
Pharmacology Biochemistry and Behavior (2020) Vol. 196, pp. 172981-172981
Open Access | Times Cited: 39
Telomere attrition and inflammatory load in severe psychiatric disorders and in response to psychotropic medications
Alessio Squassina, Mirko Manchia, Claudia Pisanu, et al.
Neuropsychopharmacology (2020) Vol. 45, Iss. 13, pp. 2229-2238
Open Access | Times Cited: 33
Inflammation is correlated with abnormal functional connectivity in unmedicated bipolar depression: an independent component analysis study of resting-state fMRI
Guixian Tang, Pan Chen, Guanmao Chen, et al.
Psychological Medicine (2021) Vol. 52, Iss. 15, pp. 3431-3441
Closed Access | Times Cited: 29
Association of Single Nucleotide Polymorphisms of Cytokine Genes with Depression, Schizophrenia and Bipolar Disorder
Ekaterina V. Mikhalitskaya, N. Vyalova, Evgeny A. Ermakov, et al.
Genes (2023) Vol. 14, Iss. 7, pp. 1460-1460
Open Access | Times Cited: 12
Anti-neuroinflammatory microRNA-146a-5p as a potential biomarker for neuronavigation-guided rTMS therapy success in medication resistant depression disorder
Giedrė Valiulienė, Vladas Valiulis, Aistė Zentelytė, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115313-115313
Open Access | Times Cited: 12
Features of immunometabolic depression as predictors of antidepressant treatment outcomes: pooled analysis of four clinical trials
Sarah R. Vreijling, Cherise R. Chin Fatt, Leanne M. Williams, et al.
The British Journal of Psychiatry (2023) Vol. 224, Iss. 3, pp. 89-97
Open Access | Times Cited: 12
Activation of the interleukin-23/Th17 axis in major depression: a systematic review and meta-analysis
Calum D. Moulton, Mantas Malys, Christopher W. P. Hopkins, et al.
European Archives of Psychiatry and Clinical Neuroscience (2024)
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top